NHS England finalises procurement to eliminate hepatitis C

1 May 2019 - After lengthy negotiations and a court battle, NHS England has reached agreement with three drug companies ...

Read more →

NICE says yes to another hepatitis C drug

23 September 2016 - A new drug which effectively treats more genotypes of hepatitis C has been recommended for use in ...

Read more →

More options to be made available to treat hepatitis C

9 September 2016 - Another ‘potential curative’ drug for people with chronic hepatitis C will be made available on the NHS. ...

Read more →

A pill too hard to swallow: how the NHS is limiting access to high priced drugs

27 July 2016 - A joint investigation by The BMJ and Cambridge and Bath universities uncovers how NHS England tried to ...

Read more →

High cost of new drugs

27 July 2016 - Why government must negotiate a better deal for publicly funded research. ...

Read more →

Hollow victories and hepatitis C

28 July 2016 - When Gilead Sciences introduced sofosbuvir based antivirals in 2014, the drugs were touted as a breakthrough for ...

Read more →

Betting on hepatitis C: how financial speculation in drug development influences access to medicines

27 July 2016 - Victor Roy and Lawrence King argue that the acquisition strategies of drug companies magnify development costs and ...

Read more →

NHS 'abandoning' thousands by rationing hepatitis C drugs

28 July 2016 - Addaction says NHS England decision to treat just 10,000 people a year with costly drugs is ‘potential ...

Read more →

NICE publishes final drug recommendations for the treatment of four separate medical conditions

25 November 2015 - Each piece of guidance looked at the cost-effectiveness of a particular drug to treat a specific medical ...

Read more →

NICE approval of new hepatitis drug could result in £700m bill for NHS

21 October 2015 - The National Institute for Health and Care Excellence has approved another treatment for hepatitis C, presenting NHS ...

Read more →